Recent FDA actions involving registered 503B facilities
This is a record of what FDA published, not a rating. Showing 167 dated actions since Oct 16, 2024 for facilities currently on FDA's list. Items marked uncertain may concern a related site.
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Warning Letter Issued 9/14/2026No document link published
-
Form FDA 483 Uncertain match · Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop Irving, TX483 Issued 09/08/2026 (PDF - 1.34MB)
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 09/03/2026 (PDF - 2MB)"). That listing is an uncertain match: Similar (not identical) name with same city and state
-
Class II recall, 1 product line(s): Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 08/28/2026 (PDF - 9.53MB)")
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table (no document link published there)No document link published
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 08/12/2026 (PDF - 1.83MB)"). That listing is an uncertain match: Name and state match but a different city (Minneapolis, MN); may be another site of the same company
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 08/12/2026 (PDF - 1.64MB)")
-
Warning Letter Issued 8/7/2026No document link published
-
Class II recall, 11 product line(s): Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 07/28/2026 (PDF - 1.60MB)")
-
Warning Letter Closeout Issued 7/27/2026No document link published
-
Warning Letter Closeout Issued 7/27/2026No document link published
-
FMD-145 Letter Issued 7/21/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 1 product line(s): Failed Impurities/Degradation Specifications
-
Amended 483 Issued 06/18/2026 (PDF - 618 KB)
-
FMD-145 Letter Issued 6/17/2026No document link published
-
Untitled Letter Issued 6/8/2026
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 06/01/2026 (PDF - 14 MB)")
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 1 product line(s): Subpotent Drug
-
Class III recall, 1 product line(s): Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of i
-
Warning Letter Issued 5/12/2026No document link published
-
Class II recall, 1 product line(s): Subpotent Drug
-
Regulatory Meeting Held 5/7/2026No document link published
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("Amended 483 Issued 05/07/2026 (PDF - 2.67 MB)")
-
Regulatory Meeting Held 5/5/2026No document link published
-
Regulatory Meeting Held 5/5/2026No document link published
-
FMD-145 Letter Issued 05/05/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
FMD-145 Letter Issued 04/22/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
Amended 483 Issued 04/14/2026 (PDF - 1.44 MB)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
FMD-145 Letter Issued 04/8/2026No document link published
-
FMD-145 Letter Issued 3/26/2026No document link published
-
FMD-145 Letter Issued 3/25/2026No document link published
-
Warning Letter Close Out Issued 03/23/2026
-
Class II recall, 5 product line(s): Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
FMD-145 Letter Issued 03/20/2026No document link published
-
FMD-145 Letter Issued 03/19/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 FDA table · BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy Temple Terrace, FLForm FDA 483 (linked from FDA's registration table)
-
Regulatory Meeting Held 3/3/2026No document link published
-
Regulatory Meeting Held 2/27/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 5 product line(s): Lack of Assurance of Sterility
-
Untitled Letter Issued 2/5/2026; document link from FDA's compounding actions page ("Untitled Letter Issued 02/05/2026 (PDF - 858 KB)")
-
Form FDA 483 (linked from FDA's registration table)
-
FMD-145 letter Matched · Wedgewood Connect, LLC, formerly registered as Leiter's Compounding San Jose, CAFMD-145 Letter Issued 01/02/2026No document link published
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 3 product line(s): Presence of particulate matter - Glass like particles.
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 1 product line(s): Incorrect Product Formulation
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Warning Letter Issued 11/07/2025
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Class III recall, 1 product line(s): Subpotent Drug
-
Class II recall, 15 product line(s): CGMP Deviations: Potential presence of metal particulate matter
-
Class II recall, 1 product line(s): Presence of Particulate Matter
-
Class III recall, 3 product line(s): Labeling: Incorrect or Missing Lot and/or Exp Date
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 1 product line(s): CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
-
Class II recall, 1 product line(s): Lack of assurance of sterility.
-
Class II recall, 1 product line(s): CGMP Deviations
-
Class I recall, 1 product line(s): Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
-
Untitled Letter Issued 09/16/2025
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 09/05/2025")
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 09/04/2025 (PDF - 1.78MB)")
-
Class II recall, 1 product line(s): Lack of Assurance of Sterility
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
Amended 483 Issued 08/08/2025 (PDF - 928 KB)
-
Class I, Class II recall, 57 product line(s): Lack of Assurance of Sterility
-
FMD-145 Letter Issued 07/29/2025No document link published
-
FMD-145 Letter Issued 07/28/2025No document link published
-
483 issued 07/25/2025 (PDF - 1,243 KB)
-
Form FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("Amended 483 Issued 07/18/2025 (PDF - 4.7MB)"). That listing is an uncertain match: Name and state match; city listed as 'Boca Raton' vs 'Raton' in FDA's registration table
-
Form FDA 483 FDA table · Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop Irving, TXForm FDA 483 issued, per FDA's registration table; document link from FDA's compounding actions page ("483 Issued 07/18/2025 (PDF - 1.60MB)"). That listing is an uncertain match: Name and state match but a different city (Hurst, TX); may be another site of the same company
-
Class II, Class III recall, 2 product line(s): Sub-Potent Drug: Subpotent assay results during stability testing.
-
Form FDA 483 FDA table · Wedgewood Connect, LLC, formerly registered as Leiter's Compounding San Jose, CAForm FDA 483 (linked from FDA's registration table)
-
FMD-145 Letter Issued 06/23/2025No document link published
-
Class III recall, 1 product line(s): Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
-
Form FDA 483 (linked from FDA's registration table)
-
Form FDA 483 (linked from FDA's registration table)
-
FMD-145 Letter Issued 06/06/2025No document link published
-
Class II recall, 6 product line(s): Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
-
Form FDA 483 (linked from FDA's registration table)
-
483 Issued 05/23/2025 (PDF - 1.27 MB)
-
FMD-145 Letter Issued 05/08/2025No document link published
-
FMD-145 Letter Issued 04/17/2025No document link published
-
Class II recall, 1 product line(s): Lack of Assurance of Sterility
-
Class II recall, 1 product line(s): Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the oute
-
Class III recall, 1 product line(s): Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
-
Warning Letter Issued 04/08/2025
-
Form FDA 483 (linked from FDA's registration table)
-
Class II recall, 5 product line(s): Lack of Assurance of Sterility: Leaking/damaged syringes.
-
483 issued 03/28/2025 (PDF - 2.72MB)
-
Class II recall, 3 product line(s): Lack of Assurance of Sterility
-
483 Issued 03/06/2025 (PDF - 698KB)
-
Class III recall, 1 product line(s): Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
-
Class I recall, 1 product line(s): Presence of Particulate Matter
-
Class II recall, 1 product line(s): Lack of Assurance of Sterility: due to a quality control process deviation
-
FMD-145 Letter Issued 02/13/2025No document link published
-
Class II recall, 1 product line(s): Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
-
Class II recall, 1 product line(s): Lack of Assurance of Sterility
-
Warning Letter (12/19/2024)
-
Warning letter Uncertain match · Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop Irving, TXWarning Letter Issued 12/17/2024
-
FMD-145 Letter Issued 11/20/2024No document link published
-
483 Issued 11/08/2024 (PDF - 1.91MB)
-
Class II recall, 1 product line(s): Lack of Sterility Assurance
Newly registered in the last 12 months (initial registration date)
- Medicinal Sciences Ltd. Co. Heath, TX
- Simple RX Solutions, P.C. Lewisburg, TN
- NLRx, LLC Cookeville, TN
- Olyx Pharma Schertz, TX
- Healthwealth Pharmacy, LLC Houston, TX
- Maxhealth Group, LLC dba New Life Rx Dallas, TX
- Ocyon Bio PR, LLC Aguadilla, PR
- Nivagen Pharmaceuticals, LLC Sacramento, CA
- Bespoke Pharmaceutical, LLC Las Vegas, NV
- IntegraDose Compounding Services, LLC Shoreview, MN
- Navinta III Inc. Boca Raton, FL
- Nexgen Formulations Folcroft, PA
- White Label Pharmacy dba Nova Pharmacy Katy, TX
- Apertus Compounding, LLC Maryland Heights, MO
Machine-readable: /data/feed.json. Email alerts are coming soon.